ARIPIPRAZOLE | N207202 | OTSUKA PHARMACEUTICAL CO LTD
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2017-00287 | 9125939 | IPR | Alkermes Pharma Ireland Limited et al. | Institution Denied | 2016-11-17 | — |
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7978064 | Sep 14, 2026 | — | — | Yes | — | — |
| 8114021 | Jun 21, 2030 | — | — | Yes | — | — |
| 8258962 | Nov 25, 2030 | — | — | Yes | — | — |
| 8545402 | Apr 27, 2030 | — | — | Yes | — | — |
| 8547248 | Dec 18, 2030 | — | — | Yes | — | |
| 8674825 | Apr 9, 2029 | — | — | Yes | — | |
| 8718193 | Dec 5, 2029 | — | — | Yes | — | — |
| 8759350 | Mar 2, 2027 | — | — | — | — | |
| 8847766 | Mar 29, 2030 | — | — | Yes | — | |
| 8945005 | Aug 19, 2029 | — | — | Yes | — | |
| 8956288 | Jul 6, 2029 | — | — | Yes | — | |
| 8961412 | Nov 17, 2030 | — | — | Yes | — | — |
| 9060708 | Mar 5, 2029 | — | — | Yes | — | — |
| 9119554 | Dec 16, 2028 | — | — | Yes | — | — |
| 9125939 | Jul 28, 2026 | — | — | — | — | |
| 9149577 | Dec 15, 2029 | — | — | Yes | — | — |
| 9258035 | Mar 5, 2029 | — | — | Yes | — | — |
| 9268909 | Oct 15, 2033 | — | — | Yes | — | |
| 9320455 | Dec 15, 2031 | — | — | Yes | — | — |
| 9433371 | Sep 15, 2029 | — | — | Yes | — | — |
| 9444503 | Nov 19, 2027 | — | — | Yes | — | |
| 9941931 | Nov 4, 2030 | — | — | Yes | — | — |
| 10441194 | Jul 26, 2029 | — | — | Yes | — | — |
| 10517507 | Jun 13, 2032 | — | — | Yes | — | — |
| 11229378 | Jul 11, 2031 | — | — | Yes | — | — |
| 11464423 | Sep 15, 2030 | — | — | Yes | — | — |
| 11476952 | Apr 28, 2026 | — | — | Yes | — | — |